APO monthly performance report
Monthly APO research: returns, drawdown, relative strength, seasonality, and key stats.
APO monthly report
—
Key takeaways
- Apollo Global Management (APO) closed September 2026 at $128.98, down 5.56% for the month and −5.44% over the trailing 12 months.
- Year-to-date, APO is −10.90%, underperforming the S&P 500 which has returned +12.08% YTD.
- The stock is trading +0.98% versus its 200-day moving average ($127.73), a bullish technical signal.
- Over the past three years, APO has underperformed the S&P 500 by −24.85%, with a relative strength index reading of 85.4.
- Win rate over the trailing 39 months stands at 59% — 23 positive months versus 16 negative months.
Apollo Global Management ended September 2026 at $128.98, posting a monthly return of −5.56%. The S&P 500 returned −0.36% over the same window, leaving relative performance at −5.20%.
The current quarter stands at +9.02% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +0.98% versus the 200-day moving average ($127.73).
Year-to-date, APO is −10.90% against SPY +12.08%, a gap of −22.98%. The stock is currently −15.86% below its 52-week high, with maximum 3-year drawdown at −43.84%.
| Period | APO | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.84% | +0.85% | −0.02% |
| 1 Week | −2.50% | −0.11% | −2.39% |
| 1 Month | −5.56% | −0.36% | −5.20% |
| 3 Months | −2.80% | +5.36% | −8.16% |
| 6 Months | +18.66% | +12.68% | +5.97% |
| YTD | −10.90% | +12.08% | −22.98% |
| 12 Months | −5.44% | +16.22% | −21.66% |
| 3 Years | +45.58% | +70.43% | −24.85% |
| Rank | Month | Return |
|---|---|---|
| #1 | Nov 2024 | +22.18% |
| #2 | Nov 2023 | +18.80% |
| #3 | Apr 2026 | +15.53% |
| #4 | Oct 2024 | +14.69% |
| #5 | Feb 2024 | +11.35% |
| Rank | Month | Return |
|---|---|---|
| #1 | Feb 2026 | −22.25% |
| #2 | Oct 2023 | −13.73% |
| #3 | Feb 2025 | −12.70% |
| #4 | Mar 2025 | −8.26% |
| #5 | Jun 2026 | −8.08% |
| Quarter | Return |
|---|---|
| Q2 2025 | +3.60% |
| Q3 2025 | −6.06% |
| Q4 2025 | +8.62% |
| Q1 2026 | −23.03% |
| Q2 2026 | +6.18% |
| Q3 2026 (QTD) | +9.02% |
| Year | Return |
|---|---|
| 2023 | +46.09% |
| 2024 | +77.23% |
| 2025 | −12.35% |
| 2026 | −10.90% |
| Metric | Value |
|---|---|
| 52-Week High | $153.29 (2026-01-06) |
| 52-Week Low | $99.56 (2026-03-03) |
| Current Price | $128.98 |
| 200-Day Moving Average | $127.73 |
| Price vs 200DMA | +0.98% |
| 3-Year Maximum Drawdown | −43.84% (2026-03-12) |
| Current Drawdown from 52W High | −15.86% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 85.4 |
| 3-Year Excess Return vs S&P 500 | −24.85% |
| RS Peak | 148.8 (Dec 2024) |
| RS Trough | 76.2 (Mar 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was APO's return for this report period?
APO returned −5.56% in the latest monthly window ending 2026-09-11.
Has APO outperformed SPY year to date?
YTD APO: −10.90% vs SPY: +12.08%.
What is APO's 12-month return?
−5.44% over the trailing 12 months.
Is APO above or below its 200-day moving average?
Price is +0.98% versus 200DMA ($127.73).
What is the maximum drawdown in the 3-year window?
−43.84% on 2026-03-12.